INDIVIOR PLC/S (OTCMKTS:INVVY)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.74 and traded as low as $4.50. INDIVIOR PLC/S shares last traded at $4.78, with a volume of 48,504 shares trading hands.
Several research analysts recently weighed in on INVVY shares. ValuEngine raised INDIVIOR PLC/S from a “sell” rating to a “hold” rating in a research report on Tuesday, May 19th. Zacks Investment Research raised INDIVIOR PLC/S from a “sell” rating to a “hold” rating in a research report on Friday, April 3rd.
The stock has a market capitalization of $700.21 million, a price-to-earnings ratio of 8.69 and a beta of 0.30. The company has a quick ratio of 1.73, a current ratio of 1.75 and a debt-to-equity ratio of 7.05. The firm has a 50-day moving average of $4.77 and a two-hundred day moving average of $3.23.
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex.
See Also: What is the Nikkei 225 index?
Receive News & Ratings for INDIVIOR PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INDIVIOR PLC/S and related companies with MarketBeat.com's FREE daily email newsletter.